Screener
Bio-Techne TECH Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|
| Distributions from Wilson Wolf | 4,620 | 2,653 |
| Investment in Spear Bio | — | (15,000) |
| Proceeds from sale of assets held-for-sale | 4,617 | 1,789 |
| Net cash provided by (used in) investing activities | (11,133) | (35,589) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Cash dividends | (37,432) | (38,004) |
| Proceeds from stock option exercises | 58,193 | 45,513 |
| Repurchases of common stock | (24) | (175,674) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's investing cash flow?
- Bio-Techne (TECH) reported investing cash flow of -$5.82M in Q1 2026.
- How has Bio-Techne's investing cash flow changed year-over-year?
- Bio-Techne's investing cash flow increased by 34.4% year-over-year, from -$8.87M to -$5.82M.
- What is the long-term trend for Bio-Techne's investing cash flow?
- Over 3 years (2022 to 2025), Bio-Techne's investing cash flow has grown at a -28.4% compound annual growth rate (CAGR), from -$96.85M to -$35.59M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Bio-Techne's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude